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Abstract
Background: Triacylglycerols (TAG) have been shown to have potential appetite suppressing effects. This study
examined the effects of 3 g and 6 g Korean pine nut triacylglycerols (PinnoThin) on appetite and energy intake.
Methods: 130 g Isoenergetic yogurt containing either placebo (milk fat) or PinnoThin TAG was consumed as a
breakfast, after an overnight fast, in a double blind randomized crossover design. Appetite profile ratings were
determined by visual analogue scale at regular intervals for a period of 4 h after the breakfast. In phase I, 6 g
PinnoThin TAG and placebo was tested in thirty-three healthy women (mean ± SD, BMI 26.4 ± 3.8 kg/m
2; age 28 ±
10 y) to determine the appetite suppressing effect in time. In phase II, an additional dose of 3 g PinnoThin TAG, as
well as 6 g PinnoThin TAG and placebo, was tested in thirty-four women (BMI 25.8 ± 2.9 kg/m
2; age 25 ± 9 y) to
determine energy intake from an ad libitum lunch offered at 210 min after the breakfast, at which maximal
differences in appetite profile ratings were present in phase I.
Results: Area under the curve of appetite profile ratings was not significantly different between the conditions.
Energy intake was 9.5% lower after 6 g PinnoThin TAG compared with 3 g PinnoThin TAG, but there was no
significant difference with the placebo.
Conclusion: A dosage of 6 g PinnoThin TAG is not sufficient to suppress appetite and energy intake.
Trial registration: Clinical Trials NCT01034605
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Introduction
An effective strategy to prevent the positive energy bal-
ance resulting in obesity is still lacking. It has been
shown that a positive energy balance of 50 kcal per day
already results in an increase in body weight of at least
one kilo per year [1]. A potential prevention strategy is
by reducing food intake via the use of (natural) appetite
suppressants.
Different macronutrients exert various postprandial
effects and stimulate the release of satiety hormones to
different degrees. Fat intake is known to induce the
release of gastro-intestinal hormones, like cholecystoki-
nin (CCK) and glucagon-like peptide-1 (GLP-1). Both
CCK and GLP-1 have shown to be involved in the
development of satiation, by suppressing appetite and
energy intake [2-5]. The satiating effect of fat is influ-
enced by chain length and the degree of saturation of
the fatty acids. Only fatty acids with chain lengths ≥
C12 are capable of reducing food intake and releasing
CCK and GLP-1 [6,7]. Furthermore, long-chain fatty
acids have been shown to be more effective than med-
ium-chain fatty acids [8,9]. Regarding the degree of
saturation, it has been shown that polyunsaturated fatty
acids (PUFAs) have a more potent effect on reducing
food intake and increasing the release of satiety hor-
mones than monounsaturated fatty acids (MUFAs) [8].
PinnoThin is an oil from Korean pine nuts (Pinus
Koraiensis) which consists of 66% polyunsaturated fatty
acids (PUFAs; linoleic (C18:2) and pinolenic acid
(C18:3)) and 26% monounsaturated fatty acids (MUFAs;
oleic acid (C18:1)) [10]. The large amounts of PUFAs in
PinnoThin suggest that PinnoThin might be able to
reduce appetite by the induction of satiety hormones.
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glycerol (TAG) and free fatty acids (FFA) can produce
an increase in CCK and GLP-1 release in post-meno-
pausal overweight women [11]. AUC of appetite ratings
were not significantly different after the consumption of
PinnoThin (FFA and TAG) [11], probably because the
study was underpowered with only 18 overweight post-
menopausal women. Moreover, observations were not
corrected for baseline measurements, leading to the
question whether the results were based upon clear sta-
tistically significant differences between treatment and
placebo. No effects of PinnoThin TAG on appetite rat-
ings were found in a study with 42 overweight women
[12]. In contrast, in the same study 2 g PinnoThin FFA
resulted in a trend for reduced energy intake (7% reduc-
tion, P = 0.09) [12]. The authors suggest that the lack of
an effect of PinnoThin TAG could be attributed to the
timing of the dosing regime. Absorption of fatty acids in
the gut from TAG is slower compared to FFA, conse-
quently the time between consumption of PinnoThin
TAG and the ad libitum lunch (30 min) was probably
too short to detect an effect.
The present study was designed to measure the effect
of PinnoThin TAG (66% PUFAs and 26% MUFAs), in a
sufficient number of subjects. In a first phase, the effect
of PinnoThin TAG on appetite ratings was evaluated.
To overcome the problem of timing of the dosing
regime we determined the sensitive moment in time, at
which maximal differences between one dosage of Pin-
noThin TAG and placebo in appetite profile ratings
were present, in this first phase. In a second phase, the
effect of two dosages of PinnoThin TAG vs. placebo on
energy intake at this previously determined relevant
time point was evaluated to determine the minimum
effective dosage.
Subjects and methods
Subjects
Thirty-nine healthy women aged 18-45 y with a BMI of
23-30 kg/m
2 were recruited by advertisements in local
newspapers and on notice boards at the university. All
subjects underwent a screening and were in good health,
regularly consuming breakfast, nonsmokers, not using
medication (except for oral contraception) and at most
moderate alcohol users. None of the subjects had a food
allergy, had gained or lost more than 5 kg in three
months prior to the study, or were cognitively dietary
restrained (F1 > 13) as assessed by a validated Dutch
translation of the Three Factor Eating Questionnaire
(TFEQ) [13]. This study was conducted according to the
guidelines laid down in the Declaration of Helsinki and
all procedures involving human subjects were approved
by the Central Committee on Human Research and by
the Medical Ethical Committee of the University of
Maastricht. Written informed consent was obtained
from all subjects.
Study protocol
The study had a double blind, randomized, crossover
design. Test day were scheduled in the same phase of
the subjects’ menstrual cycle, at least one menstrual
cycle apart. Subjects were provided with a meal to con-
sume at home on the evening prior to each test day.
They were asked to abstain from strenuous physical
activity and not to eat or drink from 2200 h the night
before the test day. The subjects reported to the univer-
sity at 0845 h after an overnight fast. At 0900 h the sub-
jects received a yogurt breakfast (130 g) containing
either PinnoThin TAG or placebo (milk fat).
The study consisted of two phases, with the results of
phase I determining the timing of the measurement in
phase II. During phase I, appetite ratings were deter-
mined at regular intervals for a period of 4 h after the
test breakfast with 6 g PinnoThin TAG or 6 g placebo.
In phase II, an ad libitum lunch was offered at the pre-
viously determined sensitive moment in time, based on
the maximal differences in appetite profile ratings in
phase I. In addition to 6 g PinnoThin TAG and 6 g pla-
cebo, an extra dose of 3 g PinnoThin TAG was tested
with a yogurt breakfast containing a mixture of 3 g Pin-
noThin TAG and 3 g milk fat.
Appetite ratings
Appetite was evaluated usinga n c h o r e d1 0 0 - m mv i s u a l
analogue scales (VAS) in both phase I and II [14,15].
Hunger, fullness, satiety, thirst, desire to eat, prospective
food consumption and nausea were assessed. The scale
was anchored from ‘not at all’ on the left to ‘extremely’
on the right. On each test day, these questionnaires
were completed before breakfast at 0855 h, after break-
fast at 0915 and 0930 h and every 30 minutes thereafter
(1000, 1030, 1100, 1130, 1200, 1230 and 1300 h).
Yogurt breakfast
Breakfast was a yogurt (130 g) containing either 6 g
milk fat, 3 g PinnoThin TAG and 3 g milk fat or 6 g
PinnoThin TAG, which provided 46, 11 and 43 En%
from carbohydrate, protein and fat respectively. The
energy content of the breakfast was 523kJ. PinnoThin
TAG consists of 66% polyunsaturated fatty acids
(PUFAs; linoleic (C18:2) and pinolenic acid (C18:3)) and
26% monounsaturated fatty acids (MUFAs). The sub-
jects were instructed to consume the yogurt within 5
minutes and to hold each spoon of yogurt in their
mouth for 5-10 seconds before swallowing.
The yogurts were produced by NIZO Food Research
b.v. (Ede, The Netherlands) with either PinnoThin TAG
(Lipid Nutrition b.v., Wormerveer, The Netherlands) or
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with a mixture of orange, apple (SVZ, Breda, The Neth-
erlands), lemon and passion fruit (Givaudan b.v., Barne-
v e l d ,T h eN e t h e r l a n d s ) .T h ey o g u r t sd i dn o td i f f e ri n
color, flavour or viscosity.
Energy intake
Food and energy intake were determined using an ad
libitum lunch in phase II. Lunch consisted of Turkish
bread (330 g) with egg salad (600 g) and was weighed
before and after eating. Subjects were instructed to eat
till they were comfortably full. The lunch had an energy
density of 11.5kJ/g with 44, 17 and 39 En% from carbo-
hydrate, protein and fat respectively.
Statistical analysis
Since baseline values did not differ, data are presented
as mean changes from baseline and their standard
errors, unless otherwise indicated. The area under the
curve (AUC) of changes from baseline over time (4 h
for appetite ratings) was calculated using the trapezoid
method. A repeated-measures ANOVA was carried out
to determine possible differences in appetite ratings and
energy intake between the PinnoThin TAG (3 g and 6
g) and placebo breakfast. Significance was defined as P
< 0.05, unless otherwise indicated. A power calculation
was performed to determine the number of subjects
required and was based on a difference in food intake
after intake of 2 g PinnoThin FFA observed in a pre-
vious study [12]. With an observed difference of 7% and
a standard deviation of 10%, it was calculated that after
taking a 15% dropout into account 30 subjects were
needed to achieve sufficient power (90%) to observe sig-
nificant (P < 0.05) changes in food intake as a result of
the treatment. All of the statistical analyses were exe-
cuted with SPSS version 16.0 for Macintosh OS X (SPSS
Inc, Chicago, IL).
Results
Subject characteristics
Thirty-three women participated in phase I. Five women
of this group did not participate in phase II, because of
personal reasons and/or lack of time. Six new female
subjects were recruited for phase II, and together with
the remaining 28, a total of 34 women completed the
second set of experiments. Subject characteristics of
both phases are presented in table 1.
Phase I
Hunger ratings were significantly decreased after 6 g
PinnoThin TAG compared with placebo at 210 min
after the breakfast (6 (SEM 4) v. 14 (SEM 4) mm VAS;
P < 0.05; Figure 1a). Prospective food consumption was
decreased after PinnoThin TAG compared to placebo at
210 min after the breakfast (0 (SEM 4) v. 8 (SEM 3)
mm VAS; P < 0.05; Figure 1e). The time-by-treatment
interaction did not reach significance and the AUC for
the appetite ratings was not significantly different
between the treatments. Based on these results, in phase
II an ad libitum l u n c hw a so f f e r e da t2 1 0m i na f t e r
breakfast with placebo, 3 g or 6 g PinnoThin TAG.
Phase II
The time-by-treatment interaction did not reach signifi-
cance and also the AUC for the appetite ratings was not
significantly different between the treatments. Appetite
ratings over time were comparable between phase I and
II.
Energy intake was decreased significantly by 9.5% after
the breakfast with 6 g PinnoThin TAG compared with
the breakfast with 3 g PinnoThin TAG (P < 0.05; Table
2). The lowered energy intake after 6 g PinnoThin TAG
did not reach significance compared with the placebo.
In addition, there was no significant difference between
energy intake after 3 g PinnoThin TAG and placebo.
These results remain similar after correcting energy
intake for body weight, height and age of each subject.
T h i sw a sd o n eb yd e f i n i n ge n e r g yi n t a k ea sa%o f
energy requirement (ER), calculated according to the
Harris-Benedict equations, multiplied by an activity
index of 1.7 [16].
Ratings of liking of the yogurt breakfast, nausea and
thirst were not different between the treatments. Nausea
ratings were extremely low and changes from baseline
over time did not become positive. No adverse events
were reported.
Discussion
The time-by-treatment interaction and differences in
AUC for the appetite ratings were not significant in
both phases. Energy intake was reduced by 9.5% after
supplementation of 6 g PinnoThin TAG compared with
3 g PinnoThin TAG. However, the reduction in energy
Table 1 Subject characteristics
Phase I Phase II
33 women 34 women*
Mean SEM Mean SEM
Age (y) 28 2 25 2
Height (m) 1.69 0.01 1.70 0.01
Body Weight (kg) 75.6 1.9 74.3 1.7
BMI (kg/m
2) 26.4 0.4 25.8 0.5
Dietary restraint
‡ 7.1 0.7 6.5 0.7
Values are expressed as mean ± SEM. BMI = Body Mass Index
*28 subjects completed both phases. Five women dropped out before phase
II was completed and therefore six new subjects were recruited for phase II.
‡Dietary restraint = Factor 1 score of the Three-Factor Eating Questionnaire
[13]
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placebo did not reach significance.
If PinnoThin TAG indeed acts as an appetite suppres-
sant, it would be expected that PinnoThin TAG sup-
presses appetite measured via appetite profile ratings
with VAS. However, the time-by-treatment interaction
was not significant. In the study of Hughes et al. [12],
there were also no effects of 6 g PinnoThin TAG on
appetite ratings, and in the study of Pasman et al. [11]
PinnoThin TAG only marginally affected appetite rat-
ings. These studies had major differences between the
study protocols. For example, PinnoThin was consumed
3.5 h after the breakfast in the Hughes study, instead of
simultaneously with a breakfast after an overnight fast
in this study, as well as the Pasman study. Previous stu-
dies supplemented PinnoThin in a capsule [11,12],
Figure 1 Changes in hunger (A), satiety (B), fullness (C), desire to eat (D) and prospective food consumption (E) (all in mm visual
analogue scale; VAS) over time (min) after a yogurt breakfast with either placebo (△) or 6 g PinnoThin TAG (▲) expressed as changes
from baseline in 33 women (phase I). Values are means, with standard errors represented by vertical bars. *P < 0.05 with repeated-measures
ANOVA.
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in a yogurt breakfast. Also, milk fat instead of olive oil
was used as a placebo in this study. In addition, the Pas-
man study was underpowered with only 18 postmeno-
pausal overweight women [11]. Our sample size was
sufficiently large to reach power.
Differences between FFA and TAG also cause the
contradictory results in the literature. FFAs have a
stronger effect on CCK release, fullness and hunger rat-
ings and energy intake compared with TAGs [17]. FFAs
can directly exert effects in the gut, whereas FFAs from
TAGs are released during intestinal lipolysis. In the
H u g h e ss t u d yf o o di n t a k e( g r a m s ) ,a n dn o te n e r g y
intake (kJ), was reduced during an ad libitum lunch 30
min after supplementation of 2 g FFA, while PinnoThin
TAG did not have an effect on food nor energy intake
[12]. It has been suggested that the short amount of
time between PinnoThin TAG supplementation and the
ad libitum lunch can explain the absence of an effect on
energy intake in Hughes study [12]. The rate of small
intestinal lipolysis of TAGs is unknown, and seems to
depend on several factors [17], like the rate of pancrea-
tic lipase secretion and also the rate of entry of TAGs
into the duodenum. In turn, the latter depends on the
rate of gastric emptying, which varies with the amount
and physical properties of the meal [18]. Therefore, the
concentration of FFA required in the intestine to sup-
press energy intake is still unclear [17]. Furthermore,
only two out of three fatty acids will become available
from TAG. This suggests that a same dosage of FFA
would elicit a stronger effect on energy intake compared
with TAG. To get around these unknown variables we
optimized the measurements by determining energy
intake at a previous determined sensitive moment in
time, at which maximal differences in appetite profile
ratings were present. However, the reduction in energy
intake after 6 g PinnoThin TAG when compared with
placebo did not reach significance. The observed effects
of PinnoThin TAG may become stronger when a higher
dose is supplemented. However, a higher dose is not
desirable for physiological and industrial reasons. With
PinnoThin TAG being a fat, a higher dose might not
result in a net reduction of total daily fat intake.
Furthermore, the acute effects of a single dose of Pin-
noThin TAG could be different from the effects after a
long-term trial, but no studies thus far have investigated
the effect of PinnoThin TAG in the long term.
In this study, unlike earlier studies, the effect of 2
dosages PinnoThin TAG on energy intake is determined
at a previously determined sensitive moment in time, in
a sufficiently large number of subjects to reach power
(to detect an effect size of 7% with a power of 90% at P
= 0.05). Although no appetite suppressing effect of Pin-
noThin TAG is found in the concentrations used in this
study, the results significantly contribute to the field of
research on potential appetite suppressants. Clearly, a
lowest dosage as possible is preferred for physiological
as well as industrial reasons. In order to find a mini-
mum effective dosage it is important to perform studies
with several dosages. Further studies need to be done to
determine whether higher concentrations of PinnoThin
TAG do have an appetite suppressing effect. From these
results we conclude that a dosage of 6 g PinnoThin
TAG is not sufficient to suppress appetite sensations
and energy intake.
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